Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment
Conditions
- Infections Caused by Anaerobic Bacteria
- Renal Impairment
Interventions
- DRUG: Levornidazole Disodium Phosphate for Injection
Sponsor
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
Collaborators
- [object Object]
- [object Object]